International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 152-156 , March 2007

Comparison between doxycycline–rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis

  • Mitra Ranjbar

      Affiliations

    • Department of Infectious Diseases, Sina Hospital, Hamedan, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 918 1113037; fax: +98 811 8267043.
    • ,
  • Fariba Keramat

      Affiliations

    • Department of Infectious Diseases, Sina Hospital, Hamedan, Iran
    • ,
  • Mojgan Mamani

      Affiliations

    • Department of Infectious Diseases, Sina Hospital, Hamedan, Iran
    • ,
  • Alireza Rostami Kia

      Affiliations

    • Department of Infectious Diseases, Sina Hospital, Hamedan, Iran
    • ,
  • Fatemeh o-sadad Khalilian

      Affiliations

    • Department of Infectious Diseases, Sina Hospital, Hamedan, Iran
    • ,
  • Seyed Hamid Hashemi

      Affiliations

    • Department of Infectious Diseases, Sina Hospital, Hamedan, Iran
    • ,
  • Marzieh Nojomi

      Affiliations

    • Department of Infectious Diseases, Iran University of Medical Sciences and Health Services, Tehran, Iran

Received 26 January 2005 ,Revised 29 July 2005 ,Accepted 9 November 2005.

  • Image Result

    Percentage of patients with fever over the course of the first four weeks of treatment with either doxycycline–rifampin–amikacin (ADR) or doxycycline–rifampin (DR).

    Percentage of patients with fever over the course of the first four weeks of treatment with either doxycycline–rifampin–amikacin (ADR) or doxycycline–rifampin (DR).

PII: S1201-9712(06)00062-2

doi: 10.1016/j.ijid.2005.11.007

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 152-156 , March 2007

Article Tools

* Image Usage & Resolution